Deuterium Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Deuterium Capital Management’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.19M	Buy
2022 Q2	–	Sell
2022 Q1	$1.13M	Hold
2021 Q4	$1.36M	Buy